Content |
The RBV Capital venture fund under control of UK "Rusbio Venchurs" is created at the end of 2014 by professionals of the venture market with experience of domestic and international transactions in the field of biomedicine. Fonda acts as the anchor private investor the leading Russian private pharmaceutical company R-Pharm Ltd.
History
2020
Investment into the developer of catheters for therapy of a serious illness of a GIT of PanDx
The RBV Capital fund created with the assistance of RVC and R-Pharm company at the end of December, 2020 invested 105 million rubles in PanDx. Under the terms of the agreement, the investment director of fund Igor Gonikhin will be a part of Board of Directors of a startup. Read more here.
Investment into Intellodzhik
The Intellodzhik company attracted 160 million rubles of investments within B round. The Skolkovo Foundation reported about it on December 23, 2020. RBV Capital also participated in a round. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |